Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth
DarioHealth Corp. (NASDAQ: DRIO) has secured a significant contract with a major healthcare system, marking its entry into the healthcare provider employer market in Q1 2025. This agreement contributes to Dario's 15 new client signings targeted for 2025.
The partnership will provide AI-powered chronic care management solutions to the healthcare system's employees, focusing on conditions including diabetes, hypertension, musculoskeletal pain, and mental health. Clinical studies demonstrate Dario's effectiveness, showing a 2.3-point reduction in A1C levels for diabetes patients and 28-30% decrease in anxiety and depression over eight weeks through its Dario Mind platform.
This milestone represents a breakthrough in healthcare system adoption of digital health solutions, traditionally a slower-moving sector due to reimbursement challenges and provider skepticism. The partnership validates Dario's approach to combining AI-driven personalization with user-friendly interfaces to bridge the gap between traditional care models and digital interventions.
DarioHealth Corp. (NASDAQ: DRIO) ha ottenuto un contratto significativo con un importante sistema sanitario, segnando il suo ingresso nel mercato dei fornitori di servizi sanitari nel primo trimestre del 2025. Questo accordo contribuisce ai 15 nuovi contratti con clienti previsti da Dario per il 2025.
La partnership fornirà soluzioni di gestione della cura cronica potenziate dall'IA ai dipendenti del sistema sanitario, concentrandosi su condizioni quali diabete, ipertensione, dolori muscoloscheletrici e salute mentale. Gli studi clinici dimostrano l'efficacia di Dario, evidenziando una riduzione di 2,3 punti nei livelli di A1C per i pazienti diabetici e una diminuzione del 28-30% dell'ansia e della depressione in otto settimane attraverso la piattaforma Dario Mind.
Questo traguardo rappresenta una svolta nell'adozione delle soluzioni di salute digitale da parte dei sistemi sanitari, un settore tradizionalmente più lento a causa delle sfide di rimborso e dello scetticismo dei fornitori. La partnership convalida l'approccio di Dario nel combinare la personalizzazione guidata dall'IA con interfacce user-friendly per colmare il divario tra i modelli di cura tradizionali e le interventi digitali.
DarioHealth Corp. (NASDAQ: DRIO) ha asegurado un contrato significativo con un importante sistema de salud, marcando su entrada en el mercado de proveedores de servicios de salud en el primer trimestre de 2025. Este acuerdo contribuye a las 15 nuevas contrataciones de clientes que Dario tiene como objetivo para 2025.
La asociación proporcionará soluciones de gestión de atención crónica impulsadas por IA a los empleados del sistema de salud, enfocándose en condiciones como diabetes, hipertensión, dolor musculoesquelético y salud mental. Los estudios clínicos demuestran la efectividad de Dario, mostrando una reducción de 2.3 puntos en los niveles de A1C para los pacientes diabéticos y una disminución del 28-30% en la ansiedad y depresión en ocho semanas a través de su plataforma Dario Mind.
Este hito representa un avance en la adopción de soluciones de salud digital por parte de los sistemas de salud, un sector que tradicionalmente ha sido más lento debido a los desafíos de reembolso y al escepticismo de los proveedores. La asociación valida el enfoque de Dario de combinar la personalización impulsada por IA con interfaces amigables para el usuario, cerrando la brecha entre los modelos de atención tradicionales y las intervenciones digitales.
DarioHealth Corp. (NASDAQ: DRIO)는 주요 의료 시스템과 중요한 계약을 체결하여 2025년 1분기에 의료 제공자 고용 시장에 진입하게 되었습니다. 이 계약은 Dario가 2025년을 목표로 하는 15개의 신규 고객 계약에 기여합니다.
이번 파트너십은 의료 시스템의 직원들에게 당뇨병, 고혈압, 근골격계 통증 및 정신 건강을 포함한 상태에 초점을 맞춘 AI 기반 만성 관리 솔루션을 제공합니다. 임상 연구는 Dario의 효과를 입증하며, 당뇨병 환자의 A1C 수치를 2.3포인트 감소시키고 Dario Mind 플랫폼을 통해 8주 동안 불안 및 우울증을 28-30% 감소시켰습니다.
이번 이정표는 전통적으로 환급 문제와 제공자의 회의론으로 인해 느리게 진행되는 분야인 디지털 건강 솔루션의 의료 시스템 채택에 있어 돌파구를 나타냅니다. 이 파트너십은 AI 기반 개인화와 사용자 친화적인 인터페이스를 결합하여 전통적인 치료 모델과 디지털 개입 간의 격차를 해소하는 Dario의 접근 방식을 검증합니다.
DarioHealth Corp. (NASDAQ: DRIO) a sécurisé un contrat significatif avec un grand système de santé, marquant son entrée sur le marché des fournisseurs de soins de santé au premier trimestre 2025. Cet accord contribue aux 15 nouvelles signatures de clients prévues par Dario pour 2025.
Le partenariat fournira des solutions de gestion des soins chroniques alimentées par l'IA aux employés du système de santé, en se concentrant sur des conditions telles que le diabète, l'hypertension, la douleur musculosquelettique et la santé mentale. Des études cliniques démontrent l'efficacité de Dario, montrant une réduction de 2,3 points des niveaux d'A1C pour les patients diabétiques et une diminution de 28-30% de l'anxiété et de la dépression sur huit semaines grâce à sa plateforme Dario Mind.
Ce jalon représente une avancée dans l'adoption des solutions de santé numérique par les systèmes de santé, un secteur traditionnellement plus lent en raison des défis de remboursement et du scepticisme des prestataires. Le partenariat valide l'approche de Dario qui consiste à combiner la personnalisation pilotée par l'IA avec des interfaces conviviales pour combler le fossé entre les modèles de soins traditionnels et les interventions numériques.
DarioHealth Corp. (NASDAQ: DRIO) hat einen bedeutenden Vertrag mit einem großen Gesundheitssystem gesichert, was den Eintritt in den Markt für Gesundheitsdienstleister im ersten Quartal 2025 markiert. Diese Vereinbarung trägt zu Darios Ziel von 15 neuen Kundenverträgen für 2025 bei.
Die Partnerschaft wird KI-gestützte Lösungen für das Management chronischer Erkrankungen für die Mitarbeiter des Gesundheitssystems bereitstellen, wobei der Fokus auf Erkrankungen wie Diabetes, Bluthochdruck, muskuloskelettalen Schmerzen und psychischer Gesundheit liegt. Klinische Studien zeigen Darios Effektivität, mit einer Reduktion der A1C-Werte um 2,3 Punkte bei Diabetes-Patienten und einer Verringerung von 28-30% bei Angst und Depression über einen Zeitraum von acht Wochen durch die Dario Mind-Plattform.
Dieser Meilenstein stellt einen Durchbruch in der Akzeptanz digitaler Gesundheitslösungen durch Gesundheitssysteme dar, die traditionell einen langsameren Fortschritt aufgrund von Erstattungsproblemen und Skepsis der Anbieter aufweisen. Die Partnerschaft bestätigt Darios Ansatz, KI-gesteuerte Personalisierung mit benutzerfreundlichen Schnittstellen zu kombinieren, um die Lücke zwischen traditionellen Versorgungsmodellen und digitalen Interventionen zu schließen.
- None.
- None.
Healthcare system collaborates with Dario to offer AI-powered chronic care management solutions as a benefit for their employee base of healthcare workers, expected to contribute to the current total of 15 new client signings in 2025, representing a significant head start in its 2025 net new client goal.
The new healthcare system contract marks a significant step for Dario. As self-insured employers, these organizations carefully evaluated Dario's ability to deliver measurable value for both employees and patients. Their decision to integrate Dario's solutions reflects confidence in the company's ability to enhance care delivery while addressing chronic conditions such as diabetes, hypertension, musculoskeletal (MSK) pain, and mental health challenges.
Dario aims to position itself at the forefront of the evolution of the digital health landscape, demonstrating the ability of digital health solutions to drive meaningful clinical outcomes. Peer-reviewed studies highlight Dario's effectiveness in reducing A1C levels for diabetes patients by 2.3 points, as well as decreasing anxiety and depression by 28
"We are thrilled to add such a unique segment to our employer book of business," said Steven Nelson, Chief Commercial Officer at Dario. "Healthcare workers have a deep understanding of the impact that poor chronic condition management can have on a person. Having our solutions trusted by this audience is truly meaningful. These employers recognize the clinical importance of Dario's cardiometabolic and behavioral health solutions, and we are excited to provide them with tools that improve health outcomes and overall well-being."
Historically, healthcare systems have been slower to adopt digital wellness and self-care therapies. Inconsistent reimbursement models and provider skepticism about engagement and clinical efficacy have all contributed to delayed integration. However, recent industry shifts—including coverage, stronger clinical evidence and more innovative approaches to engagement —are accelerating adoption.
As the digital health landscape continues to evolve, collaborations with healthcare systems will play a critical role in expanding access to high-quality, technology-enabled care. By prioritizing innovation and clinical rigor, Dario remains committed to driving the next wave of digital health adoption for both employers and healthcare providers alike.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected timing for the new contract to be operational, the belief that this milestone reinforces the growing recognition of digital health solutions among healthcare professionals, the potential benefits of its platform and products and its belief that the new contract validates the need for digital health solutions among healthcare workers, and its ability to provide real clinical outcomes and create value for employees and their organizations alike. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/3708722/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dario-signs-first-healthcare-system-as-employer-contract-expanding-market-presence-and-recurring-revenue-growth-302393022.html
SOURCE DarioHealth Corp.
FAQ
What clinical outcomes has DRIO demonstrated for diabetes and mental health management?
How many new clients is DRIO targeting to sign in 2025?
What chronic conditions does DRIO's digital health platform address?
When will DRIO's new healthcare system contract go live?
Why have healthcare systems been slower to adopt digital health solutions like DRIO?
